This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 07 15 pharma-law-policy-june-2022
Remove 2022 Related Topics
Ransomware HIPAA Fraud Health Insurance Public Health Nursing Homes Licensing Medicaid COVID-19 Vaccine Medicare More Related Topics >
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

MAY 24, 2023

Following the draft consultation in November 2022, the NMPA announced the issuance of the Regulations on the Supervision and Management of Enterprises Implementing the Main Responsibility for the Quality and Safety of Medical Devices , which will come into force on 01 March 2023.

FDA 40
FDA Licensing Governance Compliance 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

FEBRUARY 26, 2024

This follows a strong call by Member States at the 2023 June European Council , confirmed in Granada in October 2023, and from the European Parliament. This EC builds on work by the European Health Union, notably the reinforced mandate of the European Medicines Agency (EMA) and the recently published pharmaceutical reform.

FDA 52
FDA Compliance COVID-19 Public Health 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 50,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024